Translational Development Acquisition Corp. (TDACU) Cash & Equivalents (2023 - 2025)

Translational Development Acquisition (TDACU) has 2 years of Cash & Equivalents data on file, last reported at $29787.0 in Q4 2025.

• Quarterly Cash & Equivalents changed N/A year-over-year to $29787.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $29787.0 (changed N/A YoY) and the FY2025 annual result came in at $29787.0, changed N/A from the prior year.
• Cash & Equivalents slipped to $29787.0 in Q4 2025, from $47150.0 in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $47150.0 in Q3 2025 to a low of $2021.0 in Q4 2023.